A phase 1/2 study investigating intraprostatic anti-CTLA-4 and PD-1 blockade, plus radiation and ADXS-PSA in metastatic prostate cancer

Trial Profile

A phase 1/2 study investigating intraprostatic anti-CTLA-4 and PD-1 blockade, plus radiation and ADXS-PSA in metastatic prostate cancer

Planning
Phase of Trial: Phase I/II

Latest Information Update: 16 Dec 2015

At a glance

  • Drugs ADXS 31142 (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms CARAVAN
  • Most Recent Events

    • 01 Dec 2015 According to the Advaxis Inc. media release, FDA has placed ADXS- PSA trials on clinical hold.
    • 01 Dec 2015 Status changed from planning to suspended, according to the Advaxis Inc. media release.
    • 07 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top